Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 10.01M P/E - EPS this Y - Ern Qtrly Grth -
Income -13.04M Forward P/E - EPS next Y - 50D Avg Chg -31.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -61.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -91.00%
Recommedations 2.00 Quick Ratio 0.67 Shares Outstanding 3.20M 52W Low Chg 2.00%
Insider Own 4.18% ROA -416.93% Shares Float 3.06M Beta -
Inst Own 0.86% ROE - Shares Shorted/Prior 18.26K/115.73K Price 3.43
Gross Margin - Profit Margin - Avg. Volume 13,779 Target Price -
Oper. Margin - Earnings Date May 13 Volume 989 Change -2.56%
About GRI Bio, Inc.

GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on treating inflammatory, fibrotic, and autoimmune diseases in the United States. Its product pipeline comprises GRI-0621, which is in phase II clinical development for the treatment of idiopathic pulmonary fibrosis; GRI-0803 which is in phase I trial for the treatment of systematic lupus erythematosus; GRI-0124, which is in pre-clinical development for the treatment of primary sclerosing cholangitis; and GRI-0729 in pre-clinical development. The company also develops ADAIR and ADMIR for treatment of attention -deficit/hyperactivity disorder. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.

GRI Bio, Inc. News
04/29/24 GRI Bio Announces Abstracts Accepted for Presentation at the 14th International Congress on Autoimmunity
04/25/24 GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
04/16/24 GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea Patent
04/08/24 GRI Bio Announces Abstract Accepted for Poster Presentation at the 2024 American Thoracic Society International Conference
06:35 AM GRI Bio Reports Full Year 2023 Financial Results and Provides Corporate Update
03/28/24 GRI Bio to Present at the MedInvest Biotech & Pharma Investor Conference
03/14/24 GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell Modulators
03/04/24 GRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United Kingdom
02/02/24 GRI Bio Announces Pricing of $5.5 Million Public Offering
01/26/24 GRI Bio Announces Reverse Stock Split
12/06/23 GRI Bio begins patent enrollment for Phase 2a study of GRI-0621 for IPF treatment
12/05/23 GRI Bio Commences Patient Enrollment in Phase 2a Biomarker Study Evaluating Lead Program GRI-0621 for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”)
11/27/23 GRI Bio (NASDAQ: GRI) Announces FDA Clearance of IND for Lead Program GRI-0621, a Type 1 Invariant NKT (“iNKT”) Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”)
11/15/23 GRI Bio (NASDAQ: GRI) Reports Third Quarter 2023 Financial Results and Provides Corporate Update
10/31/23 GRI Bio Presents Data Supporting Innovative Pipeline of NKT Cell Modulators for the Treatment of High-Value Inflammatory, Fibrotic and Autoimmune Diseases
10/19/23 GRI Bio Presents Translational Data Demonstrating Connection Between NKT Cells and the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF) at the 2023 Pittsburgh-Ireland International Lung Conference
10/17/23 GRI Bio Announces Partnership with the Respiratory Translational Research Collaboration to Advance Leading NKT Regulation Technology Targeting Earlier in the Inflammatory Cascade to Modulate Disease Progression
10/11/23 GRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Ask the CEO Conference
10/05/23 GRI Bio Announces Publication of Comprehensive Invariant NKT (iNKT) Cell Review in Frontiers in Immunology Demonstrating a Key Role of Type 1 iNKT Cells in Modulating Various Fibrotic Conditions
09/29/23 September Is Pulmonary Fibrosis Awareness Month: Here’s What One Company Is Doing To Develop A Treatment For This Deadly Disease
GRI Chatroom

User Image LuckyRing Posted - 6 hours ago

$GRI Another RS where did you see that? Are they getting any revenue in?

User Image Lastcall Posted - 04/30/24

$GRI Your kidding another RS how can you do another one that quick wtf

User Image Simovic95 Posted - 04/30/24

$GRI they said the RS vote on 7 june, I'm waiting a good catalyst on may. Do your DD.

User Image blazertrader Posted - 04/30/24

$BBLG $GRI $PRZO This is the problem with “pumpers”. They don’t actually have a damn clue. $GRI voting on rs in early June and offering to follow. They have no money. Careful who you listen to. 😉

User Image blazertrader Posted - 04/30/24

$GRI Told ya…. This should dip hard within the next month or so. Stay away!

User Image Slowroast1 Posted - 04/29/24

$GRI another rs on the horizon, just 3 months after the last one 🤣 Anybody long on this might as well throw your money in the toilet 💩

User Image SmallSharkInBigPond Posted - 04/29/24

$GRI news 👇👇 https://www.sec.gov/Archives/edgar/data/1824293/000182429324000039/griproxystatementjune2024r.htm

User Image Stock_Titan Posted - 04/29/24

$GRI GRI Bio Announces Abstracts Accepted for Presentation at the 14th International Congress on Autoimmunity https://www.stocktitan.net/news/GRI/gri-bio-announces-abstracts-accepted-for-presentation-at-the-14th-cmkrbod4cidm.html

User Image Lastcall Posted - 04/26/24

$GRI This stock is so predictable..Someone wants this to stay down

User Image Lastcall Posted - 04/26/24

$GRI It's a rally lol. Don't worry will give it back today 😂

User Image Emxc2 Posted - 04/25/24

$GRI been watching this for sometime, whats with the AH movement daily ?

User Image INTS915 Posted - 04/25/24

$GRI, only $ 10k can manipulate this junk.

User Image Stock_Titan Posted - 04/25/24

$GRI GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar https://www.stocktitan.net/news/GRI/gri-bio-to-present-at-live-with-webull-corporate-connect-virtual-3dabzoa2z434.html

User Image INTS915 Posted - 04/24/24

$GRI , $ 40k can manipulate this garage.

User Image INTS915 Posted - 04/24/24

$GRI , who the fw11k is buying this trash ???

User Image Lastcall Posted - 04/24/24

$GRI Who paints the tape all the time pre and after 😂

User Image INTS915 Posted - 04/24/24

$GRI , reverse split announcement soon. May be in 15 days.

User Image GiraldoFetz Posted - 04/24/24

$VRME $UUU long holds $MBRX $GRI bio plays ready to go any day.

User Image BULLISH1975 Posted - 04/23/24

$GRI they have had lots of stuff going on the last year. trial results due this quarter. Micro cap Bios are reliant on news- trial results to move SP. results are close and good results will bring volume and buyers🤞 dyor- this one has been shorted and under most radars but this could change quick.

User Image INTS915 Posted - 04/23/24

$GRI , they never put gun on your head to invest in their ponzy scheme. You gambled it. And gamblers never win. This scam is going down soon.

User Image Lastcall Posted - 04/23/24

$GRI Fuck fucking CEO say something

User Image OTC_EMPRESS Posted - 04/23/24

$GRI 👀

User Image blazertrader Posted - 04/23/24

$GRI Company is running out of money quickly. Only enough for the next handful of months. Offering/split inevitable within near future. Bankruptcy is always an option as well.

User Image BULLISH1975 Posted - 04/22/24

$GRI been adding the last 2 weeks. Let's see. Sold my NUWE and put the money here. dyor

User Image blazertrader Posted - 04/22/24

@PennyStocksMom I hate to disagree with you, but $GRI is a horrific play. They only have enough money to last through Q3 of this year. Guaranteed offering/rs on the way.

User Image INTS915 Posted - 04/22/24

$GRI , don't average down here. Gamble somewhere else.

User Image Lastcall Posted - 04/22/24

$GRI Ok I wanna get off this ride now I had enough fun 😂

User Image PennyStocksMom Posted - 04/22/24

🚨 Potential swing ideas 💡 ✅️ $BBLG near 52wk low, until small float <1, recent 1/8 rs, recently announced progress with NB1 clinical program into human testing for spinal fusion ✅️ $PRZO recent IPO, near 52wk low, small float, company focused on drone technologies for commercial drones, defense drones and urban air mobility aircraft, recently announced to enter the counter unmanned aircraft system market, previously announced partnership with US-Based Autonomous Drone Vayu Aerospace corporation upcoming catalyst: 1) joining Xponential 2024 conference April 22-25 in San Diego ✅️ $GRI small float, recently announced expanding intellectual property protection for proprietary natural killer T cell modulators with Issuance of Korea patent, near 52wk low from recent offering price $1.10, recent 1/7 rs, previously announced FDA clearance of IND for lead program for the treatment of idiopathic pulmonary fibrosis , interim data from Phase 2a expected first half 2024, topline Q2

User Image INTS915 Posted - 04/22/24

$GRI , lol 😆. Cut the loss and become smart baggie.

User Image Simovic95 Posted - 04/22/24

$GRI proud to be new buggie.